Loading…

Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis

Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1)....

Full description

Saved in:
Bibliographic Details
Published in:Cancer cell international 2020-05, Vol.20 (1), p.165-165, Article 165
Main Authors: Peng, Ningfu, He, Jingrong, Li, Jindu, Huang, Hao, Huang, Weiqiao, Liao, Yingyang, Zhu, Shaoliang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c597t-4cff3035d82fd45fdaccc827d9b10d33990d2e208611776aa96ad79afa979c6d3
cites cdi_FETCH-LOGICAL-c597t-4cff3035d82fd45fdaccc827d9b10d33990d2e208611776aa96ad79afa979c6d3
container_end_page 165
container_issue 1
container_start_page 165
container_title Cancer cell international
container_volume 20
creator Peng, Ningfu
He, Jingrong
Li, Jindu
Huang, Hao
Huang, Weiqiao
Liao, Yingyang
Zhu, Shaoliang
description Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). Quantitative real-time polymerase chain reaction was used to determine MALAT1 and microRNA (miR)-146a expression in HCC tissues and cell lines. Western blotting was performed to measure PI3K, Akt, and mTOR levels. Dual-luciferase reporter assay was used to validate the direct targeting and negative regulatory interaction between miR-146a and MALAT1. Cell viability, proliferation, and apoptosis were analyzed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, colony formation assay, and flow cytometry, respectively; autophagy was detected based on LC3B expression. MALAT1 expression was higher in HCC tissues than in normal tissues. MALAT1 upregulation promoted HCC cell proliferation, whereas MALAT1 downregulation promoted HCC apoptosis and autophagy. Moreover, effects of MALAT1 downregulation on HCC cells were abolished by miR-146a inhibition. miR-146a directly targeted the 3'-untranslated region of , and PI3K protein level was clearly decreased upon miR-146a mimic transfection. MALAT1 may modulate HCC cell proliferation, apoptosis, and autophagy via sponging miR-146a, which regulates HCC progression.
doi_str_mv 10.1186/s12935-020-01231-w
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_babe3ece583a4faabbe0cc7b962c4e65</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_babe3ece583a4faabbe0cc7b962c4e65</doaj_id><sourcerecordid>2405337182</sourcerecordid><originalsourceid>FETCH-LOGICAL-c597t-4cff3035d82fd45fdaccc827d9b10d33990d2e208611776aa96ad79afa979c6d3</originalsourceid><addsrcrecordid>eNpdks1u1DAUhSMEoqXwAiyQJTZswvgvdrJBGlUURgwUVcPaurGdGQ9JHGyHdh6DNybplKpl5avrcz_bxyfLXhP8npBSLCKhFStyTHGOCWUkv36SnRIui5yWQj59UJ9kL2LcY0xkKfDz7IRRzgpSiNPsz9r3W9T7Xnvjpurq2xJ9Xa6XG4Jcv3O1SxGlnUUw-CH56CKC3iAYkx92sD0g36CdHSB5bdt2bCEgDUG73neA5haqDyhB2No002dS53Tw0zE54QIW31fsy2L5My26zeUVghsXX2bPGmijfXW3nmU_Lj5uzj_n68tPq_PlOtdFJVPOddMwzApT0sbwojGgtS6pNFVNsGGsqrChluJSECKlAKgEGFlBA5WstDDsLFsducbDXg3BdRAOyoNTtw0ftgpCcrq1qobaMqttUTLgDUBdW6y1rCtBNbeimFgfjqxhrDtrtO1TgPYR9PFO73Zq638rSen0cTPg3R0g-F-jjUl1Ls7-QW_9GBXluGBMkpJO0rf_Sfd-DP1k1azinOGi5JOKHlWT2TEG29xfhmA1p0cd06Om9Kjb9KjraejNw2fcj_yLC_sLdMrCFA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2404430584</pqid></control><display><type>article</type><title>Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis</title><source>Publicly Available Content Database</source><source>PubMed Central (Training)</source><creator>Peng, Ningfu ; He, Jingrong ; Li, Jindu ; Huang, Hao ; Huang, Weiqiao ; Liao, Yingyang ; Zhu, Shaoliang</creator><creatorcontrib>Peng, Ningfu ; He, Jingrong ; Li, Jindu ; Huang, Hao ; Huang, Weiqiao ; Liao, Yingyang ; Zhu, Shaoliang</creatorcontrib><description>Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). Quantitative real-time polymerase chain reaction was used to determine MALAT1 and microRNA (miR)-146a expression in HCC tissues and cell lines. Western blotting was performed to measure PI3K, Akt, and mTOR levels. Dual-luciferase reporter assay was used to validate the direct targeting and negative regulatory interaction between miR-146a and MALAT1. Cell viability, proliferation, and apoptosis were analyzed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, colony formation assay, and flow cytometry, respectively; autophagy was detected based on LC3B expression. MALAT1 expression was higher in HCC tissues than in normal tissues. MALAT1 upregulation promoted HCC cell proliferation, whereas MALAT1 downregulation promoted HCC apoptosis and autophagy. Moreover, effects of MALAT1 downregulation on HCC cells were abolished by miR-146a inhibition. miR-146a directly targeted the 3'-untranslated region of , and PI3K protein level was clearly decreased upon miR-146a mimic transfection. MALAT1 may modulate HCC cell proliferation, apoptosis, and autophagy via sponging miR-146a, which regulates HCC progression.</description><identifier>ISSN: 1475-2867</identifier><identifier>EISSN: 1475-2867</identifier><identifier>DOI: 10.1186/s12935-020-01231-w</identifier><identifier>PMID: 32435156</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>1-Phosphatidylinositol 3-kinase ; Adenocarcinoma ; AKT protein ; Apoptosis ; Autophagy ; Cancer therapies ; Cell cycle ; Cell proliferation ; Cell viability ; Flow cytometry ; HCC ; Hepatocellular carcinoma ; Kinases ; Liver cancer ; lncRNA ; Lung cancer ; Medical prognosis ; Metastases ; Metastasis ; MicroRNAs ; miR ; miRNA ; Neoplasia ; Phagocytosis ; PI3K ; Polymerase chain reaction ; Primary Research ; Proteins ; TOR protein ; Transcription ; Transfection ; Western blotting</subject><ispartof>Cancer cell international, 2020-05, Vol.20 (1), p.165-165, Article 165</ispartof><rights>The Author(s) 2020.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c597t-4cff3035d82fd45fdaccc827d9b10d33990d2e208611776aa96ad79afa979c6d3</citedby><cites>FETCH-LOGICAL-c597t-4cff3035d82fd45fdaccc827d9b10d33990d2e208611776aa96ad79afa979c6d3</cites><orcidid>0000-0001-8683-4978</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222315/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2404430584?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32435156$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peng, Ningfu</creatorcontrib><creatorcontrib>He, Jingrong</creatorcontrib><creatorcontrib>Li, Jindu</creatorcontrib><creatorcontrib>Huang, Hao</creatorcontrib><creatorcontrib>Huang, Weiqiao</creatorcontrib><creatorcontrib>Liao, Yingyang</creatorcontrib><creatorcontrib>Zhu, Shaoliang</creatorcontrib><title>Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis</title><title>Cancer cell international</title><addtitle>Cancer Cell Int</addtitle><description>Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). Quantitative real-time polymerase chain reaction was used to determine MALAT1 and microRNA (miR)-146a expression in HCC tissues and cell lines. Western blotting was performed to measure PI3K, Akt, and mTOR levels. Dual-luciferase reporter assay was used to validate the direct targeting and negative regulatory interaction between miR-146a and MALAT1. Cell viability, proliferation, and apoptosis were analyzed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, colony formation assay, and flow cytometry, respectively; autophagy was detected based on LC3B expression. MALAT1 expression was higher in HCC tissues than in normal tissues. MALAT1 upregulation promoted HCC cell proliferation, whereas MALAT1 downregulation promoted HCC apoptosis and autophagy. Moreover, effects of MALAT1 downregulation on HCC cells were abolished by miR-146a inhibition. miR-146a directly targeted the 3'-untranslated region of , and PI3K protein level was clearly decreased upon miR-146a mimic transfection. MALAT1 may modulate HCC cell proliferation, apoptosis, and autophagy via sponging miR-146a, which regulates HCC progression.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>Adenocarcinoma</subject><subject>AKT protein</subject><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Cancer therapies</subject><subject>Cell cycle</subject><subject>Cell proliferation</subject><subject>Cell viability</subject><subject>Flow cytometry</subject><subject>HCC</subject><subject>Hepatocellular carcinoma</subject><subject>Kinases</subject><subject>Liver cancer</subject><subject>lncRNA</subject><subject>Lung cancer</subject><subject>Medical prognosis</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>MicroRNAs</subject><subject>miR</subject><subject>miRNA</subject><subject>Neoplasia</subject><subject>Phagocytosis</subject><subject>PI3K</subject><subject>Polymerase chain reaction</subject><subject>Primary Research</subject><subject>Proteins</subject><subject>TOR protein</subject><subject>Transcription</subject><subject>Transfection</subject><subject>Western blotting</subject><issn>1475-2867</issn><issn>1475-2867</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdks1u1DAUhSMEoqXwAiyQJTZswvgvdrJBGlUURgwUVcPaurGdGQ9JHGyHdh6DNybplKpl5avrcz_bxyfLXhP8npBSLCKhFStyTHGOCWUkv36SnRIui5yWQj59UJ9kL2LcY0xkKfDz7IRRzgpSiNPsz9r3W9T7Xnvjpurq2xJ9Xa6XG4Jcv3O1SxGlnUUw-CH56CKC3iAYkx92sD0g36CdHSB5bdt2bCEgDUG73neA5haqDyhB2No002dS53Tw0zE54QIW31fsy2L5My26zeUVghsXX2bPGmijfXW3nmU_Lj5uzj_n68tPq_PlOtdFJVPOddMwzApT0sbwojGgtS6pNFVNsGGsqrChluJSECKlAKgEGFlBA5WstDDsLFsducbDXg3BdRAOyoNTtw0ftgpCcrq1qobaMqttUTLgDUBdW6y1rCtBNbeimFgfjqxhrDtrtO1TgPYR9PFO73Zq638rSen0cTPg3R0g-F-jjUl1Ls7-QW_9GBXluGBMkpJO0rf_Sfd-DP1k1azinOGi5JOKHlWT2TEG29xfhmA1p0cd06Om9Kjb9KjraejNw2fcj_yLC_sLdMrCFA</recordid><startdate>20200513</startdate><enddate>20200513</enddate><creator>Peng, Ningfu</creator><creator>He, Jingrong</creator><creator>Li, Jindu</creator><creator>Huang, Hao</creator><creator>Huang, Weiqiao</creator><creator>Liao, Yingyang</creator><creator>Zhu, Shaoliang</creator><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8683-4978</orcidid></search><sort><creationdate>20200513</creationdate><title>Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis</title><author>Peng, Ningfu ; He, Jingrong ; Li, Jindu ; Huang, Hao ; Huang, Weiqiao ; Liao, Yingyang ; Zhu, Shaoliang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c597t-4cff3035d82fd45fdaccc827d9b10d33990d2e208611776aa96ad79afa979c6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>Adenocarcinoma</topic><topic>AKT protein</topic><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Cancer therapies</topic><topic>Cell cycle</topic><topic>Cell proliferation</topic><topic>Cell viability</topic><topic>Flow cytometry</topic><topic>HCC</topic><topic>Hepatocellular carcinoma</topic><topic>Kinases</topic><topic>Liver cancer</topic><topic>lncRNA</topic><topic>Lung cancer</topic><topic>Medical prognosis</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>MicroRNAs</topic><topic>miR</topic><topic>miRNA</topic><topic>Neoplasia</topic><topic>Phagocytosis</topic><topic>PI3K</topic><topic>Polymerase chain reaction</topic><topic>Primary Research</topic><topic>Proteins</topic><topic>TOR protein</topic><topic>Transcription</topic><topic>Transfection</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peng, Ningfu</creatorcontrib><creatorcontrib>He, Jingrong</creatorcontrib><creatorcontrib>Li, Jindu</creatorcontrib><creatorcontrib>Huang, Hao</creatorcontrib><creatorcontrib>Huang, Weiqiao</creatorcontrib><creatorcontrib>Liao, Yingyang</creatorcontrib><creatorcontrib>Zhu, Shaoliang</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Cancer cell international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peng, Ningfu</au><au>He, Jingrong</au><au>Li, Jindu</au><au>Huang, Hao</au><au>Huang, Weiqiao</au><au>Liao, Yingyang</au><au>Zhu, Shaoliang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis</atitle><jtitle>Cancer cell international</jtitle><addtitle>Cancer Cell Int</addtitle><date>2020-05-13</date><risdate>2020</risdate><volume>20</volume><issue>1</issue><spage>165</spage><epage>165</epage><pages>165-165</pages><artnum>165</artnum><issn>1475-2867</issn><eissn>1475-2867</eissn><abstract>Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). Quantitative real-time polymerase chain reaction was used to determine MALAT1 and microRNA (miR)-146a expression in HCC tissues and cell lines. Western blotting was performed to measure PI3K, Akt, and mTOR levels. Dual-luciferase reporter assay was used to validate the direct targeting and negative regulatory interaction between miR-146a and MALAT1. Cell viability, proliferation, and apoptosis were analyzed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, colony formation assay, and flow cytometry, respectively; autophagy was detected based on LC3B expression. MALAT1 expression was higher in HCC tissues than in normal tissues. MALAT1 upregulation promoted HCC cell proliferation, whereas MALAT1 downregulation promoted HCC apoptosis and autophagy. Moreover, effects of MALAT1 downregulation on HCC cells were abolished by miR-146a inhibition. miR-146a directly targeted the 3'-untranslated region of , and PI3K protein level was clearly decreased upon miR-146a mimic transfection. MALAT1 may modulate HCC cell proliferation, apoptosis, and autophagy via sponging miR-146a, which regulates HCC progression.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>32435156</pmid><doi>10.1186/s12935-020-01231-w</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-8683-4978</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1475-2867
ispartof Cancer cell international, 2020-05, Vol.20 (1), p.165-165, Article 165
issn 1475-2867
1475-2867
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_babe3ece583a4faabbe0cc7b962c4e65
source Publicly Available Content Database; PubMed Central (Training)
subjects 1-Phosphatidylinositol 3-kinase
Adenocarcinoma
AKT protein
Apoptosis
Autophagy
Cancer therapies
Cell cycle
Cell proliferation
Cell viability
Flow cytometry
HCC
Hepatocellular carcinoma
Kinases
Liver cancer
lncRNA
Lung cancer
Medical prognosis
Metastases
Metastasis
MicroRNAs
miR
miRNA
Neoplasia
Phagocytosis
PI3K
Polymerase chain reaction
Primary Research
Proteins
TOR protein
Transcription
Transfection
Western blotting
title Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T18%3A09%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long%20noncoding%20RNA%20MALAT1%20inhibits%20the%20apoptosis%20and%20autophagy%20of%20hepatocellular%20carcinoma%20cell%20by%20targeting%20the%20microRNA-146a/PI3K/Akt/mTOR%20axis&rft.jtitle=Cancer%20cell%20international&rft.au=Peng,%20Ningfu&rft.date=2020-05-13&rft.volume=20&rft.issue=1&rft.spage=165&rft.epage=165&rft.pages=165-165&rft.artnum=165&rft.issn=1475-2867&rft.eissn=1475-2867&rft_id=info:doi/10.1186/s12935-020-01231-w&rft_dat=%3Cproquest_doaj_%3E2405337182%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c597t-4cff3035d82fd45fdaccc827d9b10d33990d2e208611776aa96ad79afa979c6d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2404430584&rft_id=info:pmid/32435156&rfr_iscdi=true